According to Jeremy Maggs SAHPRA plans to halve medicine approval times to boost local manufacturing in an article published in Moneyweb.
SAHPRA’s goal to halve medicine approval timelines is a significant step toward enabling faster access to treatments and fostering a stronger local pharmaceutical manufacturing industry. However, industry leaders caution that this initiative must be accompanied by broader policy measures to effectively support domestic growth and reduce import reliance.